About Telomeric repeat-binding factor 1
Telomeric repeat-binding factor 1 (TERF1) is a protein
from Homo sapiens identified by UniProt accession
P54274, 439 residues long.
MolForge cross-references it against 0 known binders and
166 disease associations.
Target properties
| Protein name | Telomeric repeat-binding factor 1 |
| UniProt accession | P54274 |
| Gene | TERF1 |
| Organism | Homo sapiens |
| Length | 439 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (166)
Diseases linked to this target (Open Targets).
- telomere length · score 0.59
- neurodegenerative disease · score 0.52
- head and neck squamous cell carcinoma · score 0.26
- ovarian cancer · score 0.23
- gastroesophageal reflux disease · score 0.23
- lung adenocarcinoma · score 0.21
- squamous cell lung carcinoma · score 0.21
- esophageal cancer · score 0.21
- gastric adenocarcinoma · score 0.21
- Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement · score 0.20
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P54274-F1 | alphafold | PREDICTED | 71.09 | — |
Amino-acid sequence (439 residues)
MAEDVSSAAP SPRGCADGRD ADPTEEQMAE TERNDEEQFE CQELLECQVQ VGAPEEEEEE EEDAGLVAEA EAVAAGWMLD FLCLSLCRAF RDGRSEDFRR TRNSAEAIIH GLSSLTACQL RTIYICQFLT RIAAGKTLDA QFENDERITP LESALMIWGS IEKEHDKLHE EIQNLIKIQA IAVCMENGNF KEAEEVFERI FGDPNSHMPF KSKLLMIISQ KDTFHSFFQH FSYNHMMEKI KSYVNYVLSE KSSTFLMKAA AKVVESKRTR TITSQDKPSG NDVEMETEAN LDTRKSVSDK QSAVTESSEG TVSLLRSHKN LFLSKLQHGT QQQDLNKKER RVGTPQSTKK KKESRRATES RIPVSKSQPV TPEKHRARKR QAWLWEEDKN LRSGVRKYGE GNWSKILLHY KFNNRTSVML KDRWRTMKKL KLISSDSED
Explore Telomeric repeat-binding factor 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets